Diana Le - DrugBank Blog

Join us on Kaysen's Quest: Learn more about Gene Therapy, Zolgensma

As a company that specializes in drug information, DrugBank always tries to remain informed about novel treatments, drug approvals, and drugs that are impacting global health. At the top of our minds lately is Zolgensma [https://www.drugbank.ca/drugs/DB15528] (Onasemnogene abeparvovec), a gene therapy indicated for the treatment

White Paper

UPDATED: COVID-19: Finding the Right Fit

With the global outbreak of COVID-19 spanning news stations and research labs across the world, the DrugBank team put their heads together to provide an overview of current data-driven approaches to identify potential COVID-19 therapies.

In the news

From Discovery to Resistance to Progress

Progress on resistance: The discovery of malacidins, a class of chemicals made by bacteria found in soil, is an exciting advancement and will hopefully make way for near future discovery of much needed broad-spectrum antibiotics.

In the news

Ketamine: the key to treatment resistant depression?

The treatment of depression can be a complex blend of art and science as the pathophysiology remains poorly understood. Here we explore Ketamine, a drug that has proven to have an important place in medicine and a possibly ground-breaking place in treatment of depression.